Biosynthesis of endogenous cardiac glycosides by mammalian adrenocortical cells: three steps forward.
Biosynthesis of endogenous cardiac glycosides by mammalian adrenocortical cells: three steps forward.
复制标题
哺乳动物肾上腺皮质细胞生物合成内源性强心苷:前进三步。
作者:
J. Hamlyn
2003 was the 50th anniversary of the isolation and identification of the mineralocorticoid aldosterone—a momentous event if only because aldosterone has been widely regarded as the last major metabolically active steroid to be described in the mammalian adrenal gland (1). In this issue of the journal, Qazzaz et al. (2) describe studies that support the possibility of de novo biosynthesis, in the adrenal, of a material whose overall physicochemical, immunocrossreactive, and chromatographic characteristics are indistinguishable from those of the cardiac glycoside (CG) digoxin and its dihydro analog (in which the lactone ring is fully saturated). Using a mouse tumor cell line derived from adrenocortical cells, the authors show that the 14C label from acetic acid, as well as that from labeled cholesterol, becomes incorporated into the two digoxin-like materials. Moreover, inhibition of hydroxymethylglutaryl (HMG)-CoA reductase with Mevastatin reduced the 14C labeling of both products while leaving the issue of side chain cleavage unanswered. Although sophisticated analytical methods were not used in the study, the fingerprinting of the endogenous products and the behavior of the 14C labeling are entirely consistent with the presence of digoxin and dihydrodigoxin or their respective isomers and, therefore, with …
影响因子:
4.8
作者:
J. Laredo;B. Hamilton;J. Hamlyn
通讯作者:
J. Laredo;B. Hamilton;J. Hamlyn
影响因子:
9.3
作者:
Qazzaz,HassanMAM;Cao,Zhimin;Bolanowski,DuaneD;Clark,BarbaraJ;ValdesJr,Roland
通讯作者:
ValdesJr,Roland